Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Harlan Korea Names President | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Harlan Korea Names President

Cho to oversee the Contract Research Services business

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kwan Goo Edmond (Ed) Cho has been appointed president of Harlan Korea. Mr. Cho will have full profit and loss responsibility and overall accountability for the Harlan Contract Research Services (CRS) business serving the Korean chemical, agrochemical and pharmaceutical markets.
 
Prior to joining the company, Mr. Cho was director of market access and business development for Zuellig Pharma Korea, which provides contract services and clinical reach to multinational companies in more than 15 countries. He also held sales, marketing and management positions of increasing responsibility with LG Life Sciences, Ltd., and served in the Special Forces of the Korean Army.
 
“Dr. Cho was selected to provide leadership to our Korean organization in an increasingly competitive and complex commercial, regulatory and technical environment because he has a proven ability to work across departments,” said Eric Hess, Harlan CRS vice president of commercial operations. “We are confident Dr. Cho can plan and execute strategies to provide top-quality service to the Korean markets.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters